Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.021 AUD | -4.55% | -22.22% | -40.00% |
16/05 | Chimeric Therapeutics Reopens Enrollment in Phase 1B Cell Therapy Study | MT |
02/05 | Chimeric Therapeutics Appoints COO; Shares Rise 4% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.00% | 12.58M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- US FDA Gives Green Signal to Chimeric Therapeutics' IND Application for Gastrointestinal Cancer Drug; Shares Jump 65%